Total medical devices industry M&A deals worth $320.6m were announced globally in March 2022, led by Fresenius Kabi’s $240m acquisition of Ivenix, according to GlobalData’s deals database.
Go deeper with GlobalData
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
The value marked a decrease of 0.3% over the previous month of $321.51m and a drop of 95.9% when compared with the last 12-month average, which stood at $7.88bn.
Comparing M&A deals value in different regions of the globe, North America held the top position, with total announced deals in the period worth $240m. At the country level, the US topped the list in terms of deal value at $240m.
In terms of volumes, Europe emerged as the top region for medical devices industry M&A deals globally, followed by North America and then Asia-Pacific.
The top country in terms of M&A deals activity in March 2022 was the US with 11 deals, followed by the UK with four and Japan with three.
In 2022, as of March, medical devices M&A deals worth $7.12bn were announced globally, marking an increase of 73.9% year on year.
medical devices industry M&A deals in March 2022: Top deals
The top five M&A deals accounted for 100% of the overall value during March 2022.
The combined value of the top five medical devices M&A deals stood at $320.55m, against the overall value of $320.6m recorded for the month.
The top five medical devices industry M&A deals of March 2022 tracked by GlobalData were:
1) Fresenius Kabi $240m acquisition deal with Ivenix
2) The $24.35m acquisition of LDPath by SourceBio International
3) BioKey and ImmunoPrecise Netherlands $21.94m acquisition deal with BioClue and BioStrand
4) The $21.06m acquisition of Sinusafe Medical by Bold Capital Enterprises
5) SD Biosensor $13.2m acquisition deal with bestbion dx
